Bank of America’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.03M Sell
429,148
-516,435
-55% -$4.84M ﹤0.01% 3497
2025
Q1
$6.72M Buy
945,583
+305,887
+48% +$2.17M ﹤0.01% 2989
2024
Q4
$7.46M Sell
639,696
-76,495
-11% -$892K ﹤0.01% 2726
2024
Q3
$14.7M Buy
716,191
+68,457
+11% +$1.41M ﹤0.01% 2314
2024
Q2
$14.5M Buy
647,734
+21,311
+3% +$477K ﹤0.01% 2233
2024
Q1
$17.2M Buy
626,423
+246,638
+65% +$6.79M ﹤0.01% 2107
2023
Q4
$11.6M Sell
379,785
-34,089
-8% -$1.04M ﹤0.01% 2276
2023
Q3
$13.1M Buy
413,874
+3,182
+0.8% +$101K ﹤0.01% 2097
2023
Q2
$16.7M Sell
410,692
-930,401
-69% -$37.9M ﹤0.01% 1877
2023
Q1
$50M Buy
1,341,093
+653,308
+95% +$24.3M 0.01% 1219
2022
Q4
$24M Buy
687,785
+386,914
+129% +$13.5M ﹤0.01% 1603
2022
Q3
$16.8M Sell
300,871
-72,764
-19% -$4.07M ﹤0.01% 1797
2022
Q2
$19.3M Buy
373,635
+36,552
+11% +$1.89M ﹤0.01% 1783
2022
Q1
$24.5M Buy
337,083
+46,588
+16% +$3.39M ﹤0.01% 1727
2021
Q4
$34.3M Sell
290,495
-8,873
-3% -$1.05M ﹤0.01% 1497
2021
Q3
$40.2M Buy
299,368
+17,108
+6% +$2.3M ﹤0.01% 1345
2021
Q2
$45.7M Sell
282,260
-57,974
-17% -$9.39M ﹤0.01% 1289
2021
Q1
$27.3M Buy
340,234
+227,657
+202% +$18.3M ﹤0.01% 1589
2020
Q4
$6.13M Buy
112,577
+53,676
+91% +$2.92M ﹤0.01% 2557
2020
Q3
$1.17M Buy
58,901
+33,925
+136% +$674K ﹤0.01% 3599
2020
Q2
$525K Sell
24,976
-10,774
-30% -$226K ﹤0.01% 4083
2020
Q1
$437K Buy
35,750
+5,912
+20% +$72.3K ﹤0.01% 4085
2019
Q4
$437K Sell
29,838
-594
-2% -$8.7K ﹤0.01% 4375
2019
Q3
$407K Sell
30,432
-38,653
-56% -$517K ﹤0.01% 4478
2019
Q2
$1.13M Sell
69,085
-33,866
-33% -$555K ﹤0.01% 3841
2019
Q1
$1.76M Buy
102,951
+78,599
+323% +$1.34M ﹤0.01% 3531
2018
Q4
$333K Sell
24,352
-13,364
-35% -$183K ﹤0.01% 4500
2018
Q3
$1.08M Sell
37,716
-88,359
-70% -$2.53M ﹤0.01% 3811
2018
Q2
$3.45M Buy
126,075
+115,513
+1,094% +$3.16M ﹤0.01% 3023
2018
Q1
$223K Buy
10,562
+1,567
+17% +$33.1K ﹤0.01% 4622
2017
Q4
$173K Sell
8,995
-17,423
-66% -$335K ﹤0.01% 4706
2017
Q3
$657K Buy
26,418
+1,113
+4% +$27.7K ﹤0.01% 4091
2017
Q2
$405K Buy
25,305
+7,465
+42% +$119K ﹤0.01% 4304
2017
Q1
$251K Buy
17,840
+14,558
+444% +$205K ﹤0.01% 4513
2016
Q4
$43K Buy
3,282
+2,632
+405% +$34.5K ﹤0.01% 5228
2016
Q3
$11K Buy
650
+518
+392% +$8.77K ﹤0.01% 5575
2016
Q2
$3K Buy
+132
New +$3K ﹤0.01% 5988